Fig. 1. NSD2 expression is upregulated in osteosarcoma and in cisplatin-resistant patients.
a NSD2 mRNA levels in 20 tumoural and matched peritumoural tissues. NSD2 expression in cisplatin-sensitive and cisplatin-resistant specimens was measured by immunohistochemistry (b) and real-time quantitative polymerase chain reaction (c). d Kaplan–Meier plot of survival time in patients with low and high NSD2 expression. IOD integrated optical density